JP7817249B2 - 免疫細胞の代謝促進用組成物 - Google Patents

免疫細胞の代謝促進用組成物

Info

Publication number
JP7817249B2
JP7817249B2 JP2023517172A JP2023517172A JP7817249B2 JP 7817249 B2 JP7817249 B2 JP 7817249B2 JP 2023517172 A JP2023517172 A JP 2023517172A JP 2023517172 A JP2023517172 A JP 2023517172A JP 7817249 B2 JP7817249 B2 JP 7817249B2
Authority
JP
Japan
Prior art keywords
ergothioneine
composition
salt
present
immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023517172A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022230494A1 (https=
Inventor
諒 勝部
斉志 渡辺
真梨子 小澤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Holdings Ltd
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of JPWO2022230494A1 publication Critical patent/JPWO2022230494A1/ja
Application granted granted Critical
Publication of JP7817249B2 publication Critical patent/JP7817249B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2023517172A 2021-04-26 2022-03-25 免疫細胞の代謝促進用組成物 Active JP7817249B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021074323 2021-04-26
JP2021074323 2021-04-26
PCT/JP2022/014256 WO2022230494A1 (ja) 2021-04-26 2022-03-25 免疫細胞の代謝促進用組成物

Publications (2)

Publication Number Publication Date
JPWO2022230494A1 JPWO2022230494A1 (https=) 2022-11-03
JP7817249B2 true JP7817249B2 (ja) 2026-02-18

Family

ID=83847368

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023517172A Active JP7817249B2 (ja) 2021-04-26 2022-03-25 免疫細胞の代謝促進用組成物

Country Status (7)

Country Link
US (1) US20240122899A1 (https=)
EP (1) EP4331582A4 (https=)
JP (1) JP7817249B2 (https=)
CN (1) CN117255683A (https=)
AU (1) AU2022265114A1 (https=)
TW (1) TW202308615A (https=)
WO (1) WO2022230494A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230000829A1 (en) * 2019-10-28 2023-01-05 Suntory Holdings Limited Composition for sleep improvement comprising ergothioneine or salt thereof
JPWO2024172002A1 (https=) * 2023-02-16 2024-08-22
CN120640987A (zh) * 2023-02-16 2025-09-12 三得利控股株式会社 含有麦角硫因的更年期症状的预防或改善用组合物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012180329A (ja) 2011-03-02 2012-09-20 Hokkaido Univ 抗微生物物質産生・分泌促進剤
JP2017218431A (ja) 2016-06-09 2017-12-14 株式会社スリービー 免疫応答活性化サイトカイン産生促進剤およびＴｈ１７細胞分化促進剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103746A (en) 1997-02-20 2000-08-15 Oxis International, Inc. Methods and compositions for the protection of mitochondria
US20020110604A1 (en) * 2000-08-11 2002-08-15 Ashni Naturaceuticals, Inc. Composition exhibiting synergistic antioxidant activity
JP5658479B2 (ja) 2009-04-27 2015-01-28 株式会社岩出菌学研究所 脂肪減少等の活性を示す組成物
CA2877861A1 (en) * 2012-06-26 2014-01-03 Entia Biosciences, Inc. A nutritional approach to improving athletic performance and reducing injury with l-ergothioneine and/or vitamin d2

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012180329A (ja) 2011-03-02 2012-09-20 Hokkaido Univ 抗微生物物質産生・分泌促進剤
JP2017218431A (ja) 2016-06-09 2017-12-14 株式会社スリービー 免疫応答活性化サイトカイン産生促進剤およびＴｈ１７細胞分化促進剤

Also Published As

Publication number Publication date
WO2022230494A1 (ja) 2022-11-03
TW202308615A (zh) 2023-03-01
CN117255683A (zh) 2023-12-19
EP4331582A4 (en) 2025-04-09
JPWO2022230494A1 (https=) 2022-11-03
AU2022265114A1 (en) 2023-10-12
EP4331582A1 (en) 2024-03-06
US20240122899A1 (en) 2024-04-18

Similar Documents

Publication Publication Date Title
JP7817249B2 (ja) 免疫細胞の代謝促進用組成物
JP7764471B2 (ja) 腎機能の低下抑制又は改善用組成物
US20240180876A1 (en) Composition for increasing red blood cells and/or hemoglobin
JP7796118B2 (ja) 白血球及び／又は好塩基球増加用組成物
WO2024038821A1 (ja) フレイル予防又は改善用組成物、及び、加齢に伴う身体活動能力低下を抑制又は改善するための組成物
US20240189284A1 (en) Composition for promoting lipolysis
HK40104910A (zh) 免疫细胞的代谢促进用组合物
WO2023090260A1 (ja) ヒスタミン－ｎ－メチルトランスフェラーゼ阻害用組成物
KR20190063536A (ko) 1-팔미토일-2-리놀레오일-3-아세틸글리세롤을 포함하는 급성 방사선 증후군의 예방 또는 치료용 조성물
WO2023063230A1 (ja) セサミン類及びエルゴチオネイン又はその塩を含有する組成物
HK40103315A (zh) 白血球及/或嗜碱细胞增加用组合物
WO2024172003A1 (ja) エルゴチオネインを含有する筋萎縮抑制用組成物及びＳｒｃチロシンキナーゼ阻害用組成物
WO2024172002A1 (ja) エルゴチオネインを含有する血管拡張用組成物
HK40103317A (zh) 肾功能的降低抑制或改善用组合物
WO2024203675A1 (ja) エルゴチオネイン又はその塩を含有する熱中症又は脱水症を予防、軽減又は改善するための組成物及び細胞内外水分を調節するための組成物
HK40124129A (zh) 预防或改善衰弱用组合物，以及用於抑制或改善伴随年龄增长的身体活动能力下降的组合物
WO2024190669A1 (ja) セサミン類化合物及びフェルラ酸又はその塩を含有する組成物
HK40104490A (zh) 脂肪分解促进用组合物
KR20250043432A (ko) 경구 조성물과, 에르고티오네인 또는 그의 염에서 유래하는 고미 및 젖 유래 세라마이드 함유 소재에서 유래하는 냄새를 억제하는 방법

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240508

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250603

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250801

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250925

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260106

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260205

R150 Certificate of patent or registration of utility model

Ref document number: 7817249

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150